Immunic, Inc. (IMUX)
Nasdaq: IMUX · Pharmaceutical Preparations · New York, US · filing with the SEC since 2004
Who owns Immunic, Inc.
As filed with the SECHolders of 5% or more
13
Vivo Opportunity Fund Holdings, L.P. holds 9.99% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G filed Feb 20, 2026 says.
Directors and officers
26
report now, of 50 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 13 named at left.
Holders of 5% or moreshare of the class, as filed
Vivo Opportunity Fund Holdings, L.P.
SCHEDULE 13G · filed Feb 20, 2026 · Common Stock, par value $0.0001 per share
Bvf Partners L P/il
SCHEDULE 13D · filed Feb 20, 2026 · Common Stock, $0.0001 par value · 9.99% in Aug 14, 2025
Janus Henderson Group PLC
SCHEDULE 13G · filed Dec 8, 2025 · Common Stock · 3% in Feb 14, 2025
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 12, 2025 · Common stock, par value $0.0001 per share · 1.55% in Feb 12, 2025
Commodore Capital LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.0001 · 9.9% in Feb 24, 2026
Avidity Partners Management LP
SCHEDULE 13G · filed Apr 17, 2026 · Common Stock, $0.0001 par value · 4.8% in Nov 14, 2025
Trails Edge Capital Partners, LP
SCHEDULE 13G · filed Feb 24, 2026 · Common Shares, no par value per share
Deep Track Capital, LP
SCHEDULE 13G · filed Mar 4, 2026 · Common Stock, $0.0001 par value
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.0001 par value · 8.22% in Feb 13, 2026
Millennium Management LLC
SCHEDULE 13G/A · filed Aug 6, 2026 · Common Stock, par value $0.0001 per share · 5.7% in May 6, 2026
Laurion Capital Management LP
SCHEDULE 13G · filed Aug 4, 2026 · Common Stock, $0.0001 par value
Aberdeen Group plc
SCHEDULE 13G/A · filed Jul 16, 2026 · Common Stock, par value $0.0001 · 6.85% in Feb 2, 2026
OrbiMed Advisors LLC
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share
Soleus Capital Master Fund, L.P.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.5% in Feb 19, 2026
Alyeska Investment Group, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.0001 par value · reported falling below 5%, from 6.24% in Feb 17, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Jan 30, 2025 · Common Stock · reported falling below 5%
683 Capital Management, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.9% in Feb 17, 2026
Soleus Capital Management, L.P.
SCHEDULE 13G/A · filed Nov 7, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
RTW Investments, LP
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
What IMUX reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.